Apollo Endosurgery Stock Beta
| APENDelisted Stock | USD 10.00 0.00 0.00% |
Apollo Endosurgery fundamentals help investors to digest information that contributes to Apollo Endosurgery's financial success or failures. It also enables traders to predict the movement of Apollo Stock. The fundamental analysis module provides a way to measure Apollo Endosurgery's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollo Endosurgery stock.
Apollo |
Apollo Endosurgery Company Beta Analysis
Apollo Endosurgery's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Apollo Endosurgery Beta | 2.32 |
Most of Apollo Endosurgery's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollo Endosurgery is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Apollo Endosurgery has a Beta of 2.323. This is 170.12% higher than that of the Health Care Equipment & Supplies sector and 123.37% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Apollo Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Endosurgery's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Endosurgery could also be used in its relative valuation, which is a method of valuing Apollo Endosurgery by comparing valuation metrics of similar companies.Apollo Endosurgery is currently under evaluation in beta category among related companies.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Apollo Endosurgery will likely underperform.
Apollo Fundamentals
| Return On Equity | -0.85 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.52) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 400.85 M | |||
| Shares Outstanding | 47.55 M | |||
| Shares Owned By Insiders | 4.28 % | |||
| Shares Owned By Institutions | 63.40 % | |||
| Number Of Shares Shorted | 462.09 K | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 9.78 X | |||
| Price To Sales | 5.78 X | |||
| Revenue | 76.86 M | |||
| Gross Profit | 42.43 M | |||
| EBITDA | (31.62 M) | |||
| Net Income | (39.84 M) | |||
| Cash And Equivalents | 74.74 M | |||
| Cash Per Share | 1.84 X | |||
| Total Debt | 33.96 M | |||
| Debt To Equity | 1.16 % | |||
| Current Ratio | 6.37 X | |||
| Book Value Per Share | 0.78 X | |||
| Cash Flow From Operations | (31.26 M) | |||
| Short Ratio | 0.35 X | |||
| Earnings Per Share | (1.06) X | |||
| Target Price | 10.0 | |||
| Number Of Employees | 22 | |||
| Beta | 2.32 | |||
| Market Capitalization | 579.72 M | |||
| Total Asset | 110.23 M | |||
| Retained Earnings | (256.75 M) | |||
| Working Capital | 8.17 M | |||
| Current Asset | 9.25 M | |||
| Current Liabilities | 1.08 M | |||
| Z Score | 7.4 | |||
| Net Asset | 110.23 M |
About Apollo Endosurgery Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Endosurgery's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Endosurgery using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Endosurgery based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Apollo Endosurgery information on this page should be used as a complementary analysis to other Apollo Endosurgery's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Apollo Stock
If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |